Using Microbial Diversity to unlock the Promise of Natural Products

Calliope Bio uses microbial diversity to unlock the promise of natural products. We are an impact-oriented public benefit corporation developing synthetic biology tools to address critical issues in health, food security, and sustainability. 

A search engine for nature

Accelerating Discovery

Immediate tractability of engineering diverse microbes and biosynthetic pathways to unlock synthetic biology solutions

Elevating Bioproduction

Using nature’s own built in diversity to unlock solutions to biosynthetic challenges

Streamlining Workflow

Our vertically integrated proprietary platform combines computational design with genetic designs appropriate for diverse host microbes

Nucleate Accelerator Team

Jaymin Patel

Ph.D., Yale University

Laura Quinto

Ph.D. Candidate, Yale University

Jonathan Sun

Ph.D. Candidate, Yale University

Kevin Christopher

M.B.A. Candidate, Yale University

Mentor Team

Hyde Patterson

Longitude Capital

Themasap Khan

Civilization Ventures

Colin Ng


Latest News

May 19, 2022 in News

Calliope wins first place in Nucleate New Haven pitch competition and Alnylam Award for Scientific Excellence

In a culmination of the Nucleate Activator Program, Calliope pitched to a panel of VC judges and was awarded first place, qualifying them us to advance to pitch at the…
Read More
April 20, 2022 in News

Calliope is accepted into the Berkeley SkyDeck Pad-13 Incubator cohort!

With access to over 50 workshops and world-renowned mentors, the Pad-13 program incubates early-stage startups with the potential to graduate to the Skydeck Accelerator program, which boasts high success rates…
Read More
December 22, 2021 in News

Calliope Bio is accepted to the Nucleate Activator program

Advised by visionary scientists, entrepreneurs, investors, and founders, Nucleate fosters the formation of pioneering biotech ventures. With an exceptional track record of successful spin-out and VC fundraising, Nucleate is accelerating…
Read More